Articles in Blog

Europe Digital Health Funding in Q3 2025: Resilience Amid Rationalisation

TL;DR Global Digital Health funding declined 23% quarter-on-quarter, yet Europe showed only a 17% drop, signalling relative resilience. $1.0 billion was invested…

October 31, 2025 by Galen Growth Read article

APAC Digital Health Funding Q3 2025: Slower Growth, Stronger Signals

A Cooling Quarter with Deeper Value Creation The APAC digital health funding Q3 2025 cycle recorded $416.3 million in new venture investments…

October 28, 2025 by Galen Growth Read article

US Digital Health Q3 2025: Caution, Consolidation, and a New Clinical AI Order

US digital health in Q3 2025 traded hype for hard evidence: fewer deals, larger checks, and AI moving from feature to infrastructure.…

October 24, 2025 by Galen Growth Read article

Beyond Funding: Evidence and Partnerships Give DiMe Seal Ventures the Edge

In the fast-paced world of digital health, credibility, validation, and trust are the key differentiators between ventures that thrive and those that…

October 21, 2025 by Galen Growth Read article

HLTH USA 2025: Why Health Systems Are Driving the Digital Health Revolution

TL;DR For startups at HLTH USA 2025, Health Systems (Healthcare Providers) have become the most active partners, accounting for 30% of all…

October 16, 2025 by Galen Growth Read article

Digital Health Q3 2025: Global Investment Cools, AI Heats, and Partnerships Redefine Growth in Digital Health

TL;DR Global Digital Health funding reached USD 20.6 billion across 964 deals in the first nine months of 2025, with Q3 2025…

October 9, 2025 by Galen Growth Read article

Who to Meet at HLTH USA 2025: Galen Growth’s Data-Led Playbook and Top 10 Series A Startups

An HLTH USA 2025 field guide for data-led networking and strategic dealmaking in digital health HLTH USA 2025 is the flagship health…

October 8, 2025 by Galen Growth Read article

Generative AI Will Redefine Market Research — How Corporates Can Turn Data into Decisions

TL;DR Generative AI in market research is transforming how corporates collect, analyse, and act on data — redefining the entire research-to-decision process.…

October 7, 2025 by Galen Growth Read article

Why GenAI Can’t Replace Human-Led, Domain-Deep Intelligence: The Galen Growth Perspective

TL;DR A recent Financial Times article spotlights the limitations of GenAI in replicating sell-side analyst tasks, especially predictive modelling and nuanced insight…

September 30, 2025 by Galen Growth Read article

Pharma’s Direct-to-Patient Pivot (2025): LillyDirect, PfizerForAll & NovoCare Models

By Galen Growth Research — Updated 09 September 2025 Big Pharma is moving from DTC advertising to Direct-to-Patient (DTP) infrastructure—brand-owned digital front…

September 25, 2025 by Galen Growth Read article

How Generative AI Will Reshape Digital Health Startups – and What They Must Do to Adapt

TLDR According to Galen Growth, at least 65% of global Digital Health companies operate with a B2B business model or a hybrid,…

September 18, 2025 by Galen Growth Read article

European Digital Health Bucks The Trend

The European Digital Health landscape is undergoing a significant transformation, evolving beyond the initial hype to a phase where tangible results and…

September 16, 2025 by Galen Growth Read article